A Cell Death Pathway Induced by Antibody-Mediated Cross-Linking of CD45 on Lymphocytes

Critical Reviews in Immunology

Volumn 23, Issue 5-6, 2003, Pages 421-440

  Steff, Ann Muriel ^a   Fortin, Marylène ^a   Philippoussis, Fabianne ^a   Lesage, Sylvie ^b   Arguin, Chantal ^a   Johnson, Pauline ^c   Hugo, Patrice ^a  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Apoptosis; Caspase independent; Monoclonal antibodies; Phosphatase

Indexed keywords

B LYMPHOCYTE RECEPTOR; CASPASE; CD4 ANTIGEN; CD45 ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; CELL SURFACE RECEPTOR; DEXAMETHASONE; DNA; FAS LIGAND; GALECTIN; HERMES ANTIGEN; IMMUNOGLOBULIN M; INTERLEUKIN 2 RECEPTOR; LIGAND; MONOCLONAL ANTIBODY; PHOSPHATASE; PROTEIN BAX; PROTEIN TYROSINE PHOSPHATASE; RNA; T LYMPHOCYTE RECEPTOR;

ANTIGEN EXPRESSION; APOPTOSIS; B LYMPHOCYTE; BONE MARROW; CELL DEATH; CONTROLLED STUDY; CROSS LINKING; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LYMPHOID CELL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; RNA SYNTHESIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE; THYMUS;

EID: 1242291779     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevImmunol.v23.i56.40     Document Type: Review

References (133)

1. Trowbridge IS, Thomas ML. CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu Rev Immunol 1994; 12:85-116.
2. Justement LB. The role of CD45 in signal transduction. Adv Immunol 1997; 66:1-65.
3. Thomas ML. The leukocyte common antigen family. Annu Rev Immunol 1989; 7:339-369.
4. Fischer EH, Charbonneau H, Tonks NK. Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes. Science 1991; 253: 401-406.
5. Penninger JM, Irie-Sasaki J, Sasaki T, Oliveira DSA. CD45: new jobs for an old acquaintance. Nat Immunol 2001; 2:389-396.
6. Poppema S, Lai R, Visser L, Yan XJ. CD45 (leucocyte common antigen) expression in T and B lymphocyte subsets. Leuk Lymphoma 1996; 20:217-222.
7. Fujii Y, Okumura M, Inada K, Nakahara K, Matsuda H. CD45 isoform expression during T cell development in the thymus. Eur J Immunol 1992; 22:1843-1850.
8. Wallace VA, Fung-Leung WP, Timms E, Gray D, Kishihara K, Loh DY, Penninger J, Mak TW. CD45RA and CD45RB high expression induced by thymic selection events. J Exp Med 1992; 176: 1657-1663.
9. Birkeland ML, Johnson P, Trowbridge IS, Pure E. Changes in CD45 isoform expression accompany antigen-induced murine T-cell activation. Proc Natl Acad Sci U S A 1989; 86:6734-6738.
10. Hathcock KS, Laszlo G, Dickler HB, Sharrow SO, Johnson P, Trowbridge IS, Hodes RJ. Expression of variable exon A-, B-, and C-specific CD45 determinants on peripheral and thymic T cell populations. J Immunol 1992; 148:19-28.
11. Rogers PR, Pilapil S, Hayakawa K, Romain PL, Parker DC. CD45 alternative exon expression in murine and human CD4+ T cell subsets. J Immunol 1992; 148: 4054-4065.
12. Beverley PC. Functional analysis of human T cell subsets defined by CD45 isoform expression. Semin Immunol 1992; 4:35-41.
13. Hardy RR, Hayakawa K. B cell development pathways. Annu Rev Immunol 2001; 19:595-621.
14. Ogimoto M, Katagiri T, Hasegawa K, Mizuno K, Yakura H. Induction of CD45 isoform switch in murine B cells by antigen receptor stimulation and by phorbol myristate acetate and ionomycin. Cell Immunol 1993; 151:97-109.
15. Hathcock KS, Hirano H, Hodes RJ. CD45 expression by murine B cells and T cells: alteration of CD45 isoforms in subpopulations of activated B cells. Immunol Res 1993; 12:21-36.
16. Trowbridge IS, Ostergaard HL, Johnson P. CD45: a leukocyte-specific member of the protein tyrosine phosphatase family. Biochim Biophys Acta 1991; 1095:46-56.
17. Krueger NX, Streuli M, Saito H. Structural diversity and evolution of human receptor-like protein tyrosine phosphatases. EMBO J 1990; 9:3241-3252.
18. Desai DM, Sap J, Silvennoinen O, Schlessinger J, Weiss A. The catalytic activity of the CD45 membrane-proximal phosphatase domain is required for TCR signaling and regulation. EMBO J 1994; 13:4002-4010.
19. Felberg J, Johnson P. Characterization of recombinant CD45 cytoplasmic domain proteins. Evidence for intramolecular and intermolecular interactions. J Biol Chem 1998; 273:17839-17845.
20. Streuli M, Krueger NX, Thai T, Tang M, Saito H. Distinct functional roles of the two intracellular phosphatase like domains of the receptor-linked protein tyrosine phosphatases LCA and LAR. EMBO J 1990; 9:2399-2407.
21. Volarevic S, Niklinska BB, Burns CM, June CH, Weissman AM, Ashwell JD. Regulation of TCR signaling by CD45 lacking transmembrane and extracellular domains. Science 1993; 260:541-544.
22. Hovis RR, Donovan JA, Musci MA, Motto DG, Goldman FD, Ross SE, Koretzky GA. Rescue of signaling by a chimeric protein containing the cytoplasmic domain of CD45. Science 1993; 260:544-546.
23. Niklinska BB, Hou D, June C, Weissman AM, Ashwell JD. CD45 tyrosine phosphatase activity and membrane anchoring are required for T-cell antigen receptor signaling. Mol Cell Biol 1994; 14:8078-8084.
24. Ashwell JD, D'Oro U. CD45 and Src-family kinases: and now for something completely different. Immunol Today 1999; 20:412-416.
25. Alberola-Ila J, Takaki S, Kerner JD, Perlmutter R. Differential signaling by lymphocyte antigen receptors. Annu Rev Immunol 1997; 15:125-154.
26. Byth KF, Conroy LA, Howlett S, Smith AJ, May J, Alexander DR, Holmes N. CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4+ CD8+ thymocytes, and B cell maturation. J Exp Med 1996; 183:1707-1718.
27. Mee PJ, Turner M, Basson MA, Costello PS, Zamoyska R, Tybulewicz VL. Greatly reduced efficiency of both positive and negative selection of thymocytes in CD45 tyrosine phosphatase-deficient mice. Eur J Immunol 1999; 29:2923-2933.
28. Kishihara K, Penninger J, Wallace VA, Kundig TM, Kawai K, Wakeham A, Timms E, Pfeffer K, Ohashi PS, Thomas ML. Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice. Cell 1993; 74:143-156.
29. Pingel JT, Thomas ML. Evidence that the leukocyte-common antigen is required for antigen-induced T lymphocyte proliferation. Cell 1989; 58:1055-1065.
30. Weaver CT, Pingel JT, Nelson JO, Thomas ML. CD8+ T-cell clones deficient in the expression of the CD45 protein tyrosine phosphatase have impaired responses to T-cell receptor stimuli. Mol Cell Biol 1991; 11:4415-4422.
31. Peyron JF, Verma S, de Waal M, Sancho J, Terhorst C, Spits H. The CD45 protein tyrosine phosphatase is required for the completion of the activation program leading to lymphokine production in the Jurkat human T cell line. Int Immunol 1991; 3:1357-1366.
32. Stone J, Conroy LA, Byth KF, Howlett S, Holmes N, Alexander DR. The role of CD45 in thymic development, apoptosis and signaling. In: Yakura H, editor. Kinases and Phosphatases in Lymphocyte and Neuronal Signaling. Tokyo: Springer, 1997: 88-99.
33. Koretzky GA, Picus J, Thomas ML, Weiss A. Tyrosine phosphatase CD45 is essential for coupling T-cell antigen receptor to the phosphatidyl inositol pathway. Nature 1990; 346:66-68.
34. Thomas ML, Brown EJ. Positive and negative regulation of Src-family membrane kinases by CD45. Immunol Today 1999; 20:406-411.
35. Burns CM, Sakaguchi K, Appella E, Ashwell JD. CD45 regulation of tyrosine phosphorylation and enzyme activity of src family kinases. J Biol Chem 1994; 269:13594-13600.
36. Alexander DR. The CD45 tyrosine phosphatase: a positive and negative regulator of immune cell function. Semin Immunol 2000; 12:349-359.
37. Roach T, Slater S, Koval M, White L, McFarland EC, Okumura M, Thomas M, Brown E. CD45 regulates Src family member kinase activity associated with macrophage integrin-mediated adhesion Curr Biol 1997; 7:408-417.
38. Shenoi H, Seavitt J, Zheleznyak A, Thomas ML, Brown EJ. Regulation of integrin-mediated T cell adhesion by the transmembrane protein tyrosine phosphatase CD45. J Immunol 1999; 162:7120-7127.
39. Shaw AS, Dustin ML. Making the T cell receptor go the distance: a topological view of T cell activation. Immunity 1997; 6:361-369.
40. Janes PW, Ley SC, Magee AI. Aggregation of lipid rafts accompanies signaling via the T cell antigen receptor. J Cell Biol 1999; 147:447-461.
41. Leupin O, Zaru R, Laroche T, Muller S, Valitutti S. Exclusion of CD45 from the T-cell receptor signaling area in antigen-stimulated T lymphocytes. Curr Biol 2000; 10:277-280.
42. Irie-Sasaki J, Sasaki T, Matsumoto W, Opavsky A, Cheng M, Welstead G, Griffiths E, Krawczyk C, Richardson CD, Aitken K, Iscove N, Koretzky G, Johnson P, Liu P, Rothstein DM, Penninger JM. CD45 is a JAK phosphatase and negatively regulates cytokine receptor signaling. Nature 2001; 409:349-354.
43. Stamenkovic I, Sgroi D, Aruffo A, Sy MS, Anderson T. The B lymphocyte adhesion molecule CD22 interacts with leukocyte common antigen CD45RO on T cells and alpha 2-6 sialyltransferase, CD75, on B cells. Cell 1991; 66:1133-1144.
44. Aruffo A, Kanner SB, Sgroi D, Ledbetter JA, Stamenkovic I. CD22-mediated stimulation of T cells regulates T-cell receptor/CD3-induced signaling. Proc Natl Acad Sci U S A 1992; 89:10242-10246.
45. Uemura K, Yokota Y, Kozutsumi Y, Kawasaki T. A unique CD45 glycoform recognized by the serum mannan-binding protein in immature thymocytes. J Biol Chem 1996; 271:4581-4584.
46. Martinez-Pomares L, Crocker PR, Da Silva R, Holmes N, Colominas C, Rudd P, Dwek R, Gordon S. Cell-specific glycoforms of sialoadhesin and CD45 are counter-receptors for the cysteine-rich domain of the mannose receptor. J Biol Chem 1999; 274: 35211-35218.
47. Wada J, Ota K, Kumar A, Wallner EI, Kanwar YS. Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin. J Clin Invest 1997; 99:2452-2461.
48. Walzel H, Schulz U, Neels P, Brock J. Galectin-1, a natural figand for the receptor-type protein tyrosine phosphatase CD45. Immunol Lett 1999; 67:193-202.
49. Fouillit M, Poirier F, Monostori E, Raphael M, Bladier D, Joubert-Caron R, Caron M. Analysis of galectin 1-mediated cell signaling by combined precipitation and electrophoresis techniques. Electrophoresis 2000; 21: 275-280.
50. Fouillit M, Joubert-Caron R, Poirier F, Bourin P, Monostori E, Levi-Strauss M, Raphael M, Bladier D, Caron M. Regulation of CD45-induced signaling by galectin-1 in Burkitt lymphoma B cells. Glycobiology 2000; 10:413-419.
51. Perillo NL, Marcus ME, Baum LG. Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death. J Mol Med 1998; 76:402-412.
52. Symons A, Cooper DN, Barclay AN. Characterization of the interaction between galectin-1 and lymphocyte glycoproteins CD45 and Thy-1. Glycobiology 2000; 10:559-563.
53. Amano M, Galvan M, He J, Baum LG. The ST6Gal I sialyltransferase selectively modifies N-glycans on CD45 to negatively regulate galectin-1 induced CD45 clustering, phosphatase modulation and T cell death. J Biol Chem 2003; 278:7469-7475.
54. Fajka-Boja R, Szemes M, Ion G, Legradi A, Caron M, Monostori E. Receptor tyrosine phosphatase, CD45 binds galectin-1 but does not mediate its apoptotic signal in T cell fines. Immunol Lett 2002; 82:149-154.
55. Nguyen JT, Evans DP, Galvan M, Pace KE, Leitenberg D, Bui TN, Baum LG. CD45 modulates galectin-1-induced T cell death: regulation by expression of core 2 O-glycans. J Immunol 2001; 167:5697-5707.
56. Lee RT, Ichikawa Y, Allen HJ, Lee YC. Binding characteristics of galactoside-binding lectin (galaptin) from human spleen. J Biol Chem 1990; 265:7864-7871.
57. Walzel H, Blach M, Hirabayashi J, Kasai KI, Brock J. Involvement of CD2 and CD3 in galectin-1 induced signaling in human Jurkat T-cells. Glycobiology 2000; 10:131-140.
58. Pace KE, Hahn HP, Pang M, Nguyen JT, Baum LG. CD7 delivers a pro-apoptotic signal during galectin-1-induced T cell death. J Immunol 2000; 165:2331-2334.
59. Baum LG, Pang M, Perillo NL, Wu T, Delegeane A, Uittenbogaart CH, Fukuda M, Seilhamer JJ. Human thymic epithelial cells express an endogenous lectin, galectin-1, which binds to core 2 O-glycans on thymocytes and T lymphoblastoid cells. J Exp Med 1995; 181:877-887.
60. Goldman SJ, Uniyal S, Ferguson LM, Golan DE, Burakoff SJ, Kiener PA. Differential activation of phosphotyrosine protein phosphatase activity in a murine T cell hybridoma by monoclonal antibodies to CD45. J Biol Chem 1992; 267:6197-6204.
61. Arendt CW, Hsi G, Ostergaard HL. Immobilized antibodies to CD45 induce rapid morphologic changes and increased tyrosine phosphorylation of p56lck-associated proteins in T cells. J Immunol 1995; 155: 5095-5103.
62. Shen F, Xu XL, Graf LH, Chong AS. CD45-cross-linking stimulates IFN-gamma production in NK cells. J Immunol 1995; 154:644-652.
63. Matsumoto K, Bochner BS, Wakiguchi H, Kurashige T. Altered expression of CD11b and CD62L after cross-linking of CD45 isoforms on human eosinophils. Int Arch Allergy Immunol 1998; 117(Suppl 1):34-39.
64. Yu Y, Rabinowitz R, Polliack A, Ben Bassat H, Schlesinger M. B-lymphocytes in CLL and NHL differ in the mRNA splicing pattern of the CD45 molecule. Eur J Haematol 2000; 64:376-384.
65. Wroblewski M, Hamann A. CD45-mediated signals can trigger shedding of lymphocyte L-selectin. Int Immunol 1997; 9:555-562.
66. Luke PP, O'Brien CA, Jevnikar AM, Zhong R. Anti-CD45RB monoclonal antibody-mediated transplantation tolerance. Curr Mol Med 2001; 1:533-543.
67. Zhang Z, Lazarovits A, Gao Z, Garcia B, Jiang J, Wang J, Xing JJ, White M, Zhong R. Prolongation of xenograft survival using monoclonal antibody CD45RB and cyclophosphamide in rat-to-mouse kidney and heart transplant models. Transplantation 2000; 69:1137-1146.
68. Basadonna GP, Auersvald L, Khuong CQ, Zheng XX, Kashio N, Zekzer D, Minozzo M, Qian H, Visser L, Diepstra A, Lazarovits AI, Popperna S, Strom TB, Rothstein DM. Antibody-mediated targeting of CD45 isoforms: a novel immunotherapeutic strategy. Proc Natl Acad Sci U S A 1998; 95:3821-3826.
69. Auersvald LA, Rothstein DM, Oliveira SC, Khuong CQ, Onodera H, Lazarovits AI, Basadonna GP. Indefinite islet allograft survival in mice after a short course of treatment with anti-CD45 monoclonal antibodies. Transplantation 1997; 63:1355-1358.
70. Lazarovits AI, Poppema S, Zhang Z, Khandaker M, Le Feuvre CE, Singhal SK, Garcia BM, Ogasa N, Jevnikar AM, White MH, Singh G, Stiller CR, Zhong RZ. Prevention and reversal of renal allograft rejection by antibody against CD45RB. Nature 1996; 380: 717-720.
71. Benveniste P, Takahama Y, Wiest DL, Nakayama T, Sharrow SO, Singer A. Engagement of the external domains of CD45 tyrosine phosphatase can regulate the differentiation of immature CD4+CD8+ thymocytes into mature T cells. Proc Natl Acad Sci U S A 1994; 91:6933-6937.
72. Perillo NL, Pace KE, Seilhamer JJ, Baum LG. Apoptosis of T cells mediated by galectin-1. Nature 1995; 378:736-739.
73. Perillo NL, Uittenbogaart CH, Nguyen JT, Baum LG. Galectin-1, an endogenous lectin produced by thymic epithelial cells, induces apoptosis of human thymocytes. J Exp Med 1997; 185:1851-1858.
74. Pace KE, Lee C, Stewart PL, Baum LG. Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1. J Immunol 1999; 163:3801-3811.
75. Klaus SJ, Sidorenko SP, Clark EA. CD45 ligation induces programmed cell death in T and B lymphocytes. J Immunol 1996; 156:2743-2753.
76. Lesage S, Steff AM, Philippoussis F, Page M, Trop S, Mateo V, Hugo P. CD4+ CD8+ thymocytes are preferentially induced to die following CD45 cross-linking, through a novel apoptotic pathway. J Immunol 1997; 159:4762-4771.
77. Fortin M, Steff AM, Felberg J, Ding I, Schraven B, Johnson P, Hugo P. Apoptosis mediated through CD45 is independent of its phosphatase activity and association with leukocyte phosphatase-associated phosphoprotein. J Immunol 2002; 168:6084-6089.
78. Earnshaw WC, Martins LM, Kaufmann SH. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 1999; 68:383-424.
79. Strasser A, O'Connor L, Dixit VM. Apoptosis signaling. Annu Rev Biochem 2000; 69:217-245.
80. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998; 281:1312-1316.
81. Leist M, Jaattela M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2001; 2:589-598.
82. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM, Kroemer G. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999; 397: 441-446.
83. Yang Y, Fang S, Jensen JP, Weissman AM, Ashwell JD. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science 2000; 288:874-877.
84. Fadok VA, de Cathelineau A, Daleke DL, Henson PM, Bratton DL. Loss of phospholipid asymmetry and surface exposure of phosphatidylserine is required for phagocytosis of apoptotic cells by macrophages and fibroblasts. J Biol Chem 2001; 276:1071-1077.
85. Zhuang J, Ren Y, Snowden RT, Zhu H, Gogvadze V, Savill JS, Cohen GM. Dissociation of phagocyte recognition of cells undergoing apoptosis from other features of the apoptotic program. J Biol Chem 1998; 273:15628-15632.
86. Hirt UA, Gantner F, Leist M. Phagocytosis of nonapoptotic cells dying by caspase-independent mechanisms. J Immunol 2000; 164:6520-6529.
87. McIlroy D, Tanaka M, Sakahira H, Fukuyama H, Suzuki M, Yamamura K, Ohsawa Y, Uchiyama Y, Nagata S. An auxiliary mode of apoptotic DNA fragmentation provided by phagocytes. Genes Dev 2000; 14:549-558.
88. Savill J, Fadok V. Corpse clearance defines the meaning of cell death. Nature 2000; 407:784-788.
89. Mateo V, Lagneaux L, Bron D, Biron G, Armant M, Delespesse G, Sarfati M. CD47 ligation induces caspase-independent cell death in chronic lymphocytic leukemia. Nat Med 1999; 5:1277-1284.
90. Mateo V, Brown EJ, Biron G, Rubio M, Fischer A, Deist FL, Sarfati M. Mechanisms of CD47-induced caspase-independent cell death in normal and leukemic cells: link between phosphatidylserine exposure and cytoskeleton organization. Blood 2002; 100: 2882-2890.
91. Pettersen RD, Bernard G, Olafsen MK, Pourtein M, Lie SO. CD99 signals caspase-independent T cell death. J Immunol 2001; 166:4931-4942.
92. Hyman R, Trowbridge I, Stallings V, Trotter J. Revertant expressing a structural variant of T200 glycoprotein. Immunogenetics 1982; 15:413-420.
93. Altin JG, Sloan EK. The role of CD45 and CD45-associated molecules in T cell activation. Immunol Cell Biol 1997; 75:430-445.
94. Takeda A, Maizel AL, Kitamura K, Ohta T, Kimura S. Molecular cloning of the CD45-associated 30-kDa protein. J Biol Chem 1994; 269:2357-2360.
95. Schraven B, Kirchgessner H, Gaber B, Samstag Y, Meuer S. A functional complex is formed in human T lymphocytes between the protein tyrosine phosphatase CD45, the protein tyrosine kinase p56lck and pp32, a possible common substrate. Eur J Immunol 1991; 21:2469-2477.
96. Schraven B, Schoenhaut D, Bruyns E, Koretzky G, Eckerskorn C, Wallich R, Kirchgessner H, Sakorafas P, Labkovsky B, Ratnofsky S. LPAP, a novel 32-kDa phosphoprotein that interacts with CD45 in human lymphocytes. J Biol Chem 1994; 269:29102-29111.
97. Schraven B, Schirren A, Kirchgessner H, Siebert B, Meuer SC. Four CD45/P56lck-associated phosphoproteins (pp29-pp32) undergo alterations in human T cell activation. Eur J Immunol 1992; 22:1857-1863.
98. Johnson KG, Bromley SK, Dustin ML, Thomas ML. A supramolecular basis for CD45 tyrosine phosphatase regulation in sustained T cell activation. Proc Natl Acad Sci U S A 2000; 97:10138-10143.
99. Rodgers W, Rose JK. Exclusion of CD45 inhibits activity of p56lck associated with glycolipid-enriched membrane domains. J Cell Biol 1996; 135:1515-1523.
100. Bourguignon LY, Suchard SJ, Nagpal ML, Glenney JR. A T-lymphoma transmembrane glycoprotein (gp180) is linked to the cytoskeletal protein, fodrin. J Cell Biol 1985; 101:477-487.
101. Lokeshwar VB, Bourguignon LY. Tyrosine phosphatase activity of lymphoma CD45 (GP180) is regulated by a direct interaction with the cytoskeleton. J Biol Chem 1992; 267:21551-21557.
102. Shinkai Y, Rathbun G, Lam KP, Oltz EM, Stewart V, Mendelsohn M, Charron J, Datta M, Young F, Stall AM. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 1992; 68:855-867.
103. Hugo P, Boyd RL, Waanders GA, Petrie HT, Scollay R. Timing of deletion of autoreactive V beta 6+ cells and down-modulation of either CD4 or CD8 on phenotypically distinct CD4+8+ subsets of thymocytes expressing intermediate or high levels of T cell receptor. Int Immunol. 1991; 3:265-272.
104. Ong CJ, Chui D, Teh HS, Marth JD. Thymic CD45 tyrosine phosphatase regulates apoptosis and MHC-restricted negative selection. J Immunol 1994; 152: 3793-3805.
105. Hardy RR, Carmack CE, Shinton SA, Kemp JD, Hayakawa K. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J Exp Med 1991; 173:1213-1225.
106. Kaye J, Vasquez NJ, Hedrick SM. Involvement of the same region of the T cell antigen receptor in thymic selection and foreign peptide recognition. J Immunol 1992; 148:3342-3353.
107. Philpott KL, Viney JL, Kay G, Rastan S, Gardiner EM, Chae S, Hayday AC, Owen MJ. Lymphoid development in mice congenitally lacking T cell receptor alpha beta-expressing cells. Science 1992; 256: 1448-1452.
108. Deans JP, Ledbetter JA, Pilarski LM. Differential modulation of human multinegative (CD3-4-8-) thymocyte proliferation by monoclonal antibodies to CD45RA or to CD45. Immunol Cell Biol 1994; 72: 292-299.
109. Yang Y, Ashwell JD. Thymocyte apoptosis. J Clin Immunol 1999; 19:337-349.
110. Reichlin A, Hu Y, Meffre E, Nagaoka H, Gong S, Kraus M, Rajewsky K, Nussenzweig MC. B cell development is arrested at the immature B cell stage in mice carrying a mutation in the cytoplasmic domain of immunoglobulin beta. J Exp Med 2001; 193:13-23.
111. Rolink AG, Brocker T, Bluethmann H, Kosco-Vilbois MH, Andersson J, Melchers F. Mutations affecting either generation or survival of cells influence the pool size of mature B cells. Immunity 1999; 10:619-628.
112. Freitas AA, Rocha B. Population biology of lymphocytes: the flight for survival. Annu Rev Immunol 2000; 18:83-111.
113. Lenardo M, Chan KM, Homung F, McFarland H, Siegel R, Wang J, Zheng L. Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment. Annu Rev Immunol 1999; 17:221-253.
114. Desai DM, Sap J, Schlessinger J, Weiss A. Ligand-mediated negative regulation of a chimeric transmembrane receptor tyrosine phosphatase. Cell 1993; 73: 541-554.
115. Takeda A, Wu JJ, Maizel AL. Evidence for monomeric and dimeric forms of CD45 associated with a 30-kDa phosphorylated protein. J Biol Chem 1992; 267:16651-16659.
116. Novak TJ, Farber D, Leitenberg D, Hong SC, Johnson P, Bottomly K. Isoforms of the transmembrane tyrosine phosphatase CD45 differentially affect T cell recognition. Immunity 1994; 1:109-119.
117. Schraven B, Samstag Y, Altevogt P, Meuer SC. Association of CD2 and CD45 on human T lymphocytes. Nature 1990; 345:71-74.
118. Torimoto Y, Dang NH, Vivier E, Tanaka T, Schlossman SF, Morimoto C. Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes. J Immunol 1991; 147:2514-2517.
119. Brown VK, Ogle EW, Burkhardt AL, Rowley RB, Bolen JB, Justement LB. Multiple components of the B-cell antigen receptor complex associate with the protein tyrosine phosphatase, CD45. J Biol Chem 1994; 269:17238-17244.
120. Nemecek ER, Matthews DC. Antibody-based therapy of human leukemia. Curr Opin Hematol 2002; 9:316-321.
121. Countouriotis A, Moore TB, Sakamoto KM. Cell surface antigen and molecular targeting in the treatment of hematologic malignancies. Stem Cells 2002; 20:215-229.
122. Ruffner KL, Matthews DC. Current uses of monoclonal antibodies in the treatment of acute leukemia. Semin Oncol 2000; 27:531-539.
123. Tan J, Town T, Abdullah L, Wu Y, Placzek A, Small B, Kroeger J, Crawford F, Richards D, Mullan M. CD45 isoform alteration in CD4+ T cells as a potential diagnostic marker of Alzheimer's disease. J Neuroimmunol 2002; 132:164-172.
124. Jacobsen M, Schweer D, Ziegler A, Gaber R, Schock S, Schwinzer R, Wonigeit K, Lindert RB, Kantard O, Schaefer-Klein J, Schipper HI, Oertel WH, Heidenreich F, Weinshenker BG, Sommer N, Hemmer B. A point mutation in PTPRC is associated with the development of multiple sclerosis. Nat Genet 2000; 26:495-499.
125. Neidhart M, Pataki F, Michel BA, Fehr K. CD45 isoforms expression on CD4+ and CD8+ peripheral blood T-lymphocytes is related to auto-immune processes and hematological manifestations in systemic lupus erythematosus. Schweiz Med Wochenschr 1996; 126:1922-1925.
126. Tchilian EZ, Wallace DL, Wells RS, Flower DR, Morgan G, Beverley PC. A deletion in the gene encoding the CD45 antigen in a patient with SCID. J Immunol 2001; 166:1308-1313.
127. Kung C, Pingel JT, Heikinheimo M, Klemola T, Varkila K, Yoo LI, Vuopala K, Poyhonen M, Uhari M, Rogers M, Speck SH, Chatila T, Thomas ML. Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease. Nat Med 2000; 6:343-345.
128. Lockshin RA, Zakeri Z. Caspase-independent cell deaths. Curr Opin Cell Biol 2002; 14:727-733.
129. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001; 411:342-348.
130. Jaattela M. Escaping cell death: survival proteins in cancer. Exp Cell Res 1999; 248:30-43.
131. Bellosillo B, Villamor N, Lopez-Guillermo A, Marce S, Esteve J, Campo E, Colomer D, Montserrat E. Complement-mediated cell death induced by rituximab in B-cell lymphoproliferative disorders is mediated in vitro by a caspase-independent mechanism involving the generation of reactive oxygen species. Blood 2001; 98:2771-2777.
132. Pettersen RD, Hestdal K, Olafsen MK, Lie SO, Lindberg FP. CD47 signals T cell death. J Immunol 1999; 162:7031-7040.
133. Deas O, Dumont C, MacFarlane M, Rouleau M, Hebib C, Harper F, Hirsch F, Charpentier B, Cohen GM, Senik A. Caspase-independent cell death induced by anti-CD2 or staurosporine in activated human peripheral T lymphocytes. J Immunol 1998; 161:3375-3383.